Veru share price today

(VERU)

Veru share price is $0.75 & ₹64.36 as on 7 Jan 2025, 2.30 'hrs' IST

$0.75

▲

0.02

(2.16%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Veru share price in Dollar and Rupees. Guide to invest in Veru stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Veru, along with analyst recommendations, forecasts, and comprehensive financials.

Veru share price movements

Today's Low: $0.70
Today's High: $0.83
$0.75
6.67%
Downside
Day's Volatility :15.88%
Upside
9.87%
52 Weeks Low: $0.36
52 Weeks High: $1.92
$0.75
52.0%
Downside
52 Weeks Volatility :81.25%
Upside
60.94%

Veru Returns

Period	Veru Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	-11.36%	-3.9%	0.0%
6 Months	-11.62%	1.2%	0.0%
1 Year	32.17%	8.8%	0.0%
3 Years	-86.19%	1.3%	-19.8%

Veru Key Statistics

in dollars & INR

Previous Close	$0.7375
Open	$0.776
Today's High	$0.83215
Today's Low	$0.7
Market Capitalization	$95.2M
Today's Volume	$2.7M
52 Week High	$1.92
52 Week Low	$0.36
Revenue TTM	$14.1M
EBITDA	$-65.0M
Earnings Per Share (EPS)	$-0.28
Profit Margin	-265.42%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-126.72%

How to invest in Veru from India?

It is very easy for Indian residents to invest directly in Veru from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Veru stock in both Indian Rupees (INR) and US Dollars (USD). Search for Veru or VERU on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Veru or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Veru shares which would translate to 1.144 fractional shares of Veru as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Veru, in just a few clicks!

Returns in Veru for Indian investors in Rupees

Investment Value

₹1,00,000

Veru investment value today

Current value as on today

₹1,37,151

Returns

₹37,151

(+37.15%)

Returns from Veru Stock

₹33,929 (+33.93%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Veru

-28.36%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Veru from India has reduced in the last 30 days as on Jan 7, 2025. -28.36% less purchase transactions for Veru in the last 30 days versus the previous period.

30%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Veru on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 30% more investors are searching Veru in the last 30 days versus the previous period.

Global Institutional Holdings in Veru

Adage Capital Partners Gp LLC
5.37%
BlackRock Inc
5.23%
Perceptive Advisors LLC
4.98%
Vanguard Group Inc
4.24%
Millennium Management LLC
3.79%
Morgan Stanley - Brokerage Accounts
2.06%

Analyst Recommendation on Veru

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Veru(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Veru

What analysts predicted

Upside of 353.33%

Current:

$0.75

Target:

$3.40

Insights on Veru

Price Movement
In the last 7 days, VERU stock has moved up by 16.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 3.95M → 6.65M (in $), with an average increase of 40.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -10.96M → -8.53M (in $), with an average increase of 28.6% per quarter
VERU vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 141.9%

Veru Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$31.8M	↑ 100.47%
Net Income	$-12.0M	↓ 49.8%
Net Profit Margin	-37.79%	↑ 113.1%

	FY20	Y/Y Change
Revenue	$42.6M	↑ 33.92%
Net Income	$-19.0M	↑ 57.88%
Net Profit Margin	-44.55%	↓ 6.76%

	FY21	Y/Y Change
Revenue	$61.3M	↑ 43.83%
Net Income	$7.4M	↓ 138.97%
Net Profit Margin	12.07%	↑ 56.62%

	FY22	Y/Y Change
Revenue	$39.4M	↓ 35.76%
Net Income	$-83.8M	↓ 1232.97%
Net Profit Margin	-212.88%	↓ 224.95%

	FY23	Y/Y Change
Revenue	$16.3M	↓ 58.59%
Net Income	$-93.1M	↑ 11.12%
Net Profit Margin	-571.2%	↓ 358.32%

	FY24	Y/Y Change
Revenue	$16.9M	↑ 3.62%
Net Income	$-37.8M	↓ 59.39%
Net Profit Margin	-223.86%	↑ 347.34%

	Q2 FY23	Q/Q Change
Revenue	$3.3M	↓ 49.27%
Net Income	$6.3M	↓ 116.28%
Net Profit Margin	188.98%	↑ 778.0%

	Q3 FY23	Q/Q Change
Revenue	$3.9M	↑ 15.59%
Net Income	$-23.8M	↓ 476.42%
Net Profit Margin	-615.43%	↓ 804.41%

	Q4 FY23	Q/Q Change
Revenue	$2.1M	↓ 44.57%
Net Income	$-8.3M	↓ 65.18%
Net Profit Margin	-386.6%	↑ 228.83%

	Q1 FY24	Q/Q Change
Revenue	$4.1M	↑ 93.17%
Net Income	$-10.0M	↑ 21.15%
Net Profit Margin	-242.45%	↑ 144.15%

	Q2 FY24	Q/Q Change
Revenue	$4.0M	↓ 4.39%
Net Income	$-11.0M	↑ 9.4%
Net Profit Margin	-277.42%	↓ 34.97%

	Q3 FY24	Q/Q Change
Revenue	$6.7M	↑ 68.35%
Net Income	$-8.5M	↓ 22.23%
Net Profit Margin	-128.15%	↑ 149.27%

	FY19	Y/Y Change
Profit	$21.7M	↑ 146.59%

	FY20	Y/Y Change
Profit	$30.8M	↑ 42.16%

	FY21	Y/Y Change
Profit	$47.9M	↑ 55.67%

	FY22	Y/Y Change
Profit	$30.6M	↓ 36.17%

	FY23	Y/Y Change
Profit	$7.6M	↓ 75.27%

	FY24	Y/Y Change
Profit	$5.9M	↓ 22.63%

	Q2 FY23	Q/Q Change
Profit	$1.2M	↓ 69.93%

	Q3 FY23	Q/Q Change
Profit	$1.5M	↑ 25.24%

	Q4 FY23	Q/Q Change
Profit	$1.2M	↓ 25.35%

	Q1 FY24	Q/Q Change
Profit	$678.3K	↓ 41.04%

	Q2 FY24	Q/Q Change
Profit	$1.3M	↑ 97.26%

	Q3 FY24	Q/Q Change
Profit	$2.7M	↑ 100.84%

	FY19	Y/Y Change
Operating Cash Flow	$-5.5M	↓ 52.49%
Investing Cash Flow	$-108.5K	↑ 114.23%
Financing Cash Flow	$8.1M	↓ 32.7%

	FY20	Y/Y Change
Operating Cash Flow	$-1.9M	↓ 64.81%
Investing Cash Flow	$-105.8K	↓ 2.54%
Financing Cash Flow	$9.3M	↑ 14.76%

	FY21	Y/Y Change
Operating Cash Flow	$-15.6M	↑ 706.75%
Investing Cash Flow	$14.6M	↓ 13926.92%
Financing Cash Flow	$109.7M	↑ 1076.04%

	FY22	Y/Y Change
Operating Cash Flow	$-47.5M	↑ 205.09%
Investing Cash Flow	$4.3M	↓ 70.82%
Financing Cash Flow	$1.1M	↓ 99.03%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-18.4M	↓ 27.88%
Investing Cash Flow	$6.0M	↓ 4319.54%
Financing Cash Flow	$5.2M	↑ 128.0%

Veru Technicals Summary

Sell

Neutral

Buy

Veru is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Veru Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Veru Inc	5.45%	-11.62%	32.17%	-86.19%	-81.04%
Regeneron Pharmaceuticals, Inc.	-8.86%	-31.87%	-20.46%	15.59%	87.28%
Biontech Se	-4.16%	43.82%	3.49%	-49.66%	167.6%
Alnylam Pharmaceuticals, Inc.	-8.45%	-8.03%	19.03%	56.02%	98.44%
Vertex Pharmaceuticals Incorporated	-14.11%	-16.23%	-2.87%	81.78%	76.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Veru Inc	NA	NA	0.0	-0.3	-1.27	-0.64	NA	0.26
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Veru Inc	Buy	$95.2M	-81.04%	NA	-265.42%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	87.28%	17.61	33.61%
Biontech Se	Buy	$27.3B	167.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	98.44%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	76.8%	32.84	-4.51%

About Veru

the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries

Organization	Veru
Employees	189
CEO	Dr. Mitchell S. Steiner F.A.C.S., M.D.
Industry	Consumer Non-Durables

Management People of Veru

Name	Title
Dr. Mitchell S. Steiner F.A.C.S., M.D.	Chairman, President & CEO
Dr. Harry Fisch F.A.C.S., M.D.	Vice Chairman & Chief Corporate Officer
Ms. Michele Greco CPA	CFO & Chief Administrative Officer
Dr. K. Gary Barnette Ph.D.	Chief Scientific Officer
Mr. Samuel Fisch	Executive Director of Investor Relations & Corporate Communications
Mr. Michael J. Purvis J.D.	Executive VP, General Counsel & Corporate Strategy and Secretary
Mr. Kevin J. Gilbert CPA, J.D.	Executive Vice President of Corporate Development
Mr. Martin Tayler	Executive Vice President of FC2 Global Operations
Mr. Philip R. Greenberg J.D.	Executive VP & Deputy General Counsel
Dr. Domingo Rodriguez M.D.	Executive Vice President of Global Clinical Operations

Important FAQs about investing in Veru from India :

What is Veru share price today?

Veru share price today stands at $0.75, Open: $0.78 ; Previous Close: $0.74 ; High: $0.83 ; Low: $0.70 ; 52 Week High: $1.92 ; 52 Week Low: $0.36. The stock opens at $0.78, after a previous close of $0.74. The stock reached a daily high of $0.83 and a low of $0.70, with a 52-week high of $1.92 and a 52-week low of $0.36.

Can Indians buy Veru shares?

Yes, Indians can invest in the Veru (VERU) from India.

With INDmoney, you can buy Veru at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Veru at zero transaction cost.

How can I buy Veru shares from India?

It is very easy to buy Veru from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Veru be purchased?

Yes, you can buy fractional shares of Veru with INDmoney app.

What are the documents required to start investing in Veru stocks?

To start investing in Veru, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Veru

Today’s highest price of Veru (VERU) is $0.83.

Today’s lowest price of Veru (VERU) is $0.70.

What is today's market capitalisation of Veru

Today's market capitalisation of Veru VERU is 95.2M

What is the 52 Week High and Low Range of Veru

52 Week High
$1.92
52 Week Low
$0.36

What are the historical returns of Veru?

1 Month Returns
5.45%
3 Months Returns
-11.62%
1 Year Returns
32.17%
5 Years Returns
-81.04%

Who is the Chief Executive Officer (CEO) of Veru

Dr. Mitchell S. Steiner F.A.C.S., M.D. is the current Chief Executive Officer (CEO) of Veru.

Discover More

Explore all